Literature DB >> 32141344

Infant wheezing and prenatal antibiotic exposure and mode of delivery: a prospective birth cohort study.

Daleniece Higgins1, Wilfried Karmaus1, Yu Jiang1, Pratik Banerjee1, Irshad M Sulaiman2, Hasan S Arshad3,4,5.   

Abstract

Introduction: Assessments on whether prenatal antibiotic exposure and mode of delivery increase the risk of wheezing in infants and toddlers are inconsistent. Our goal is to evaluate the association between prenatal antibiotic use and Cesarean section with three subtypes of wheezing in infancy.
Methods: An ongoing prospective three generations cohort study provides data on prenatal antibiotic use and mode of delivery. Respective questionnaire data was used to distinguish three subtypes of wheezing: any wheezing, infectious wheezing, and noninfectious wheezing. Repeated measurements of wheezing at 3, 6, and 12 months were analyzed using generalized estimation equations. Latent transition analysis assessed patterns of infant wheezing development in the first year of life.
Results: The prevalence of any wheezing was highest at 12 months (40.1%). The prevalence of infectious wheezing was higher (3 months 23.8%, 6 months 33.5%, 12 months 38.5%) than of noninfectious wheezing (3 months 13.0%, 6 months 14.0%, 12 months 11.1%). About 11-13% of children had both infectious and noninfectious wheezing at 3, 6, and 12 months (3 months 10.7%, 6 months 13.9%, 12 months 13.1%). Children born via Cesarean section have approximately a 70-80% increase in the risk of any wheezing (RR = 1.83, 95% CI 1.29-2.60) and of infectious wheezing (RR = 1.72, 95% CI 1.18-2.50).Conclusions: Analyses of infectious and noninfectious wheezing subtypes suggests that children born by Cesarean sections may be more susceptible to infectious wheezing, warranting investigations into microbial factors of infectious wheezing. No significant associations were found between prenatal antibiotic exposure and wheezing types.

Entities:  

Keywords:  Prenatal antibiotic use; cohort study; infant; infectious and noninfectious wheezing; mode of delivery

Mesh:

Substances:

Year:  2020        PMID: 32141344      PMCID: PMC7592169          DOI: 10.1080/02770903.2020.1734023

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903


  42 in total

1.  Cohort Profile: The Isle Of Wight Whole Population Birth Cohort (IOWBC).

Authors:  S Hasan Arshad; John W Holloway; Wilfried Karmaus; Hongmei Zhang; Susan Ewart; Linda Mansfield; Sharon Matthews; Claire Hodgekiss; Graham Roberts; Ramesh Kurukulaaratchy
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

2.  The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study.

Authors:  Wiesław Jedrychowski; Aleksander Gałaś; Robin Whyatt; Frederica Perera
Journal:  Int J Occup Med Environ Health       Date:  2006       Impact factor: 1.843

3.  Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years.

Authors:  S Dom; J H J Droste; M A Sariachvili; M M Hagendorens; E Oostveen; C H Bridts; W J Stevens; M H Wieringa; J J Weyler
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

4.  Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy.

Authors:  Frederika A van Nimwegen; John Penders; Ellen E Stobberingh; Dirkje S Postma; Gerard H Koppelman; Marjan Kerkhof; Naomi E Reijmerink; Edward Dompeling; Piet A van den Brandt; Isabel Ferreira; Monique Mommers; Carel Thijs
Journal:  J Allergy Clin Immunol       Date:  2011-08-27       Impact factor: 10.793

5.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

6.  Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease?

Authors:  J H Droste; M H Wieringa; J J Weyler; V J Nelen; P A Vermeire; H P Van Bever
Journal:  Clin Exp Allergy       Date:  2000-11       Impact factor: 5.018

Review 7.  The infant microbiome development: mom matters.

Authors:  Noel T Mueller; Elizabeth Bakacs; Joan Combellick; Zoya Grigoryan; Maria G Dominguez-Bello
Journal:  Trends Mol Med       Date:  2014-12-11       Impact factor: 11.951

8.  The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database.

Authors:  Tricia M McKeever; Sarah A Lewis; Chris Smith; Richard Hubbard
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

9.  Mode of delivery and development of atopic disease during the first 2 years of life.

Authors:  Kathrin Negele; Joachim Heinrich; Michael Borte; Andrea von Berg; Beate Schaaf; Irina Lehmann; H-Erich Wichmann; Gabriele Bolte
Journal:  Pediatr Allergy Immunol       Date:  2004-02       Impact factor: 6.377

Review 10.  Role of viral respiratory infections in asthma and asthma exacerbations.

Authors:  William W Busse; Robert F Lemanske; James E Gern
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.